Patients who use cannabis reduce their use in medications for pain, anxiety, migraine and sleep disorders

Patients who use cannabis reduce their use in medications for pain, anxiety, migraine and sleep disorders

Di: IACM Terapeutico

In an online survey of 1,513 patients, who receive cannabis from dispensaries, researchers from different scientific institutions across the USA revealed that a large number significantly reduced their use of several other medications.

Among respondents that regularly used opioids, over three-quarters (76.7%) indicated that they reduced their use since they started the medical use of cannabis. Approximately two-thirds of patients decreased their use of anti-anxiety drugs (71.8%), followed by medications for migraine (66.7%), sleep disorders (65.2%), alcohol (42.0%) and antidepressants (37.6%). Authors wrote that “a majority of patients reported using les opioids as well as fewer medications to treat anxiety, migraines, and sleep after initiating MC [medical cannabis]”.

Piper BJ, DeKeuster RM, Beals ML, Cobb CM, Burchman CA, Perkinson L, Lynn ST, Nichols SD, Abess AT. Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep. J Psychopharmacol. 2017 Mar 1. [in press]

Source: IACM Bulletin

Kannabia seed Company vende ai suoi clienti un prodotto da collezione, un souvenir. Non possiamo e non dobbiamo dare consigli sulla coltivazione perché il nostro prodotto non è destinato a tale scopo.

Non siamo responsabili dell’uso illecito che potrebbe essere fatto da parte di terzi delle informazioni qui pubblicate. La coltivazione della cannabis per autoconsumo è un’attività soggetta a determinate restrizioni legali che variano da stato a stato. Si consiglia di rivedere la normativa vigente nel Paese di residenza per evitare di incorrere nello svolgimento di un’attività illecita.

Condividere: